Is Apropharm-Sophatra on an FDA import alert?

No listing for Apropharm-Sophatra appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Mali page.

Has FDA refused shipments from Apropharm-Sophatra?

Yes. FDA refused 1 shipment line from Apropharm-Sophatra on November 1, 2024. The most recent, on November 1, 2024, was herbals & botanicals (not teas), n.e.c., charged as UNAPPROVED (unapproved new drug).

Why did FDA refuse Apropharm-Sophatra's shipments?

The most frequent charge is UNAPPROVED (unapproved new drug, 1 line).

What is Apropharm-Sophatra's FEI number?

Apropharm-Sophatra's FDA Establishment Identifier (FEI) is 3032192207.

Apropharm-Sophatra

FDA import alert and refusal historyTorokorobougou, MaliFEI 3032192207

Recorded by FDA as APROPHARM-SOPHATRA

Watch this supplier

As of October 26, 2026, Apropharm-Sophatra is not on any FDA import alert in SupplierRadar's records; FDA refused 1 of its shipment line on November 1, 2024, most often for unapproved new drug (UNAPPROVED).

Data from FDA public records, last checked October 26, 2026. Request a correction

Current status

Import alerts: Not listed
Last import refusal: Nov 1, 2024Herbals & botanicals (not teas), n.e.c. · UNAPPROVED
Last warning letter: None found
Last inspection: None on record

Every FDA record for Apropharm-Sophatra

1 record, newest first. Each line links to the FDA page it came from.

2024

Nov 1, 2024Import refusal
Refused, Herbals & botanicals (not teas), n.e.c.UNAPPROVEDEntry 799-3485332-7
Source

Refusal charges, in plain English

UNAPPROVED1 refused line
Unapproved new drug
The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

Questions about Apropharm-Sophatra

Is Apropharm-Sophatra on an FDA import alert?: No listing for Apropharm-Sophatra appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Mali page.
Has FDA refused shipments from Apropharm-Sophatra?: Yes. FDA refused 1 shipment line from Apropharm-Sophatra on November 1, 2024. The most recent, on November 1, 2024, was herbals & botanicals (not teas), n.e.c., charged as UNAPPROVED (unapproved new drug).
Why did FDA refuse Apropharm-Sophatra's shipments?: The most frequent charge is UNAPPROVED (unapproved new drug, 1 line).
What is Apropharm-Sophatra's FEI number?: Apropharm-Sophatra's FDA Establishment Identifier (FEI) is 3032192207.

Watch this supplier

Get an email when FDA publishes anything new on Apropharm-Sophatra.

An email with the FDA source, and a dated PDF for your FSVP file. First supplier free.

Watch this supplier

Related records

Guides

Get this record's changes by email

Watch this supplier

Buying from Apropharm-Sophatra?

Watch it and get the FDA record the day it changes. Free for one supplier.

Watch this supplier

SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.